Searched for
ACUTE THERAPIES GROWTH
Indian pharma market's double-digit growth momentum is likely to continue further: EquirusThe Indian Pharmaceutical Market is set for continued double-digit growth. May's performance showed strong demand across all therapies. Chr...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Q4 FY26 earnings: Metal companies lead growth, backed by robust volumes and favourable pricing trendsET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...
- Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...
- Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAlkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- Pharma market picks up pace, sees 10% value growth in NovIndia's pharmaceutical market rebounded in November with 9.9% value growth and 3.1% volume growth. Key therapy areas like cardiac, gastroin...
- India's pharma sector registers strong Q2 FY25 growth, driven by North America market: ReportThe major pharmaceutical companies of the country reported a 10 per cent year-on-year (YoY) growth in the second quarter of FY25, largely d...
- Sales of Electral jump 26% in hottest April on recordIndia's pharma market took a dip in March after poor sales of respiratory and anti-infective therapies dropped post-winter. April saw the m...
- Major domestic drug firms to report 8-10% revenue growth in FY24: IcraLeading domestic pharmaceutical companies in India are predicted to see an 8-10% increase in revenue in the current fiscal year, according ...
- India's pharma sector growth accelerates in May due to low base effectThe ratings agency opined that the 47.8 per cent YoY growth in India's pharmaceutical market (IPM) during May 2021 was led by a low base ef...
- India's pharmaceutical market posts 10% growth in OctoberThe revival was on the back of therapies, including cardiac and anti-diabetic, which grew by 19.5% and 9.7% respectively in October (over S...
- Pharma retail market shrinks 12% in April, worst in 3 yearsDomestic pharma retail market saw growth declining by 12% in April, sharpest falls in three years.
- New drug provides fresh hope for cancer patientsA new type of cancer therapy has produced dramatic results in patients with advanced leukaemia in an early-phase clinical trial, scientists...
- Chronic illness sees a spurt in business opportunity for pharma marketAccording to data from AIOCD, the Indian pharma market has grown at a compound annual growth rate of 3.3% in volume terms in the past five ...
- Pharma companies hope to post double-digit growth following cap on price of formulation packsAnalysts say the 18.8% growth in September compared to the year-ago period, the highest in recent months, has raised hopes of a better perf...
- GSK Pharma: Investors must be careful of the competitive threats it faces in IndiaWhile the company's performance in the June quarter was strong sequentially, it will be interesting to see GSK's strategies to overcome the...
- GSK Pharma posts its lowest revenue growth at 3.3%GSK Pharma's March quarter performance reflected the company's failure to maintain its trajectory of recovery. At 3.3%, GSK Pharma has post...
Load More
